Author:
Thompson C.A.,Charlson M.E.,Schenkein E.,Wells M.T.,Furman R.R.,Elstrom R.,Ruan J.,Martin P.,Leonard J.P.
Funder
Agency for Healthcare Research and Quality
National Institutes of Health
Reference17 articles.
1. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis;Edelman;J Gen Intern Med,1997
2. Follow-up of patients with Hodgkin’s disease following curative treatment: the routine CT scan is of little value;Dryver;Br J Cancer,2003
3. Detection of relapse in diffuse large B-cell lymphoma (DLBCL) and Hodgkin’s lymphoma (HL): observations and implications for post-remission radiologic surveillance;Xavier;Blood (ASH Annual Meeting Abstracts),2006
4. Who actually detects relapse in Hodgkin lymphoma: patient or physician?;Foltz;Blood (ASH Annual Meeting Abstracts),2004
5. The role of FDG-PET scans in patients with lymphoma;Seam;Blood,2007
Cited by
150 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献